$2.2 million raised to build VR tools for amblyopia
Treatment for binocular vision disorders is available at more than 90 clinics across the world.
Colin Kerr
Published: Tuesday, May 23, 2017
[caption id="attachment_8371" align="alignnone" width="800"]
Image Credit: Vivid Vision[/caption]
Medical technology company Vivid Vision has announced that it has raised $2.2 million to build Virtual Reality (VR) tools that could be used to treat amblyopia.
The company says its VR treatment for binocular vision disorders is available at more than 90 clinics across the world.
Founded in 2014, Vivid Vision applies virtual reality to the field of vision care. Its founder and CEO, James Blaha, a programmer and lifelong sufferer of amblyopia, started the company after experimenting on himself. Before building the first prototype, Blaha couldn’t read with his weak eye or see in 3D.
Since then, according to Vivid Vision, the vision in Blaha’s weak eye has improved to nearly 20/20. Vivid Vision launched its clinical vision therapy suite in late 2015 for optometrists and ophthalmologists and since then, the 90 clinics using it have treated more than 6,000 patients. On average, treatment lasts eight months, with patients coming one or two times a week to use the VR system.
www.seevividly.com
“It is a unique, far more efficient solution to treat Amblyopia, as well as a wide array of binocular vision dysfunction,” said Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”
Image Credit: Vivid Vision[/caption]
Medical technology company Vivid Vision has announced that it has raised $2.2 million to build Virtual Reality (VR) tools that could be used to treat amblyopia.
The company says its VR treatment for binocular vision disorders is available at more than 90 clinics across the world.
Founded in 2014, Vivid Vision applies virtual reality to the field of vision care. Its founder and CEO, James Blaha, a programmer and lifelong sufferer of amblyopia, started the company after experimenting on himself. Before building the first prototype, Blaha couldn’t read with his weak eye or see in 3D.
Since then, according to Vivid Vision, the vision in Blaha’s weak eye has improved to nearly 20/20. Vivid Vision launched its clinical vision therapy suite in late 2015 for optometrists and ophthalmologists and since then, the 90 clinics using it have treated more than 6,000 patients. On average, treatment lasts eight months, with patients coming one or two times a week to use the VR system.
www.seevividly.com
“It is a unique, far more efficient solution to treat Amblyopia, as well as a wide array of binocular vision dysfunction,” said Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”
Tags: amblyopia
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.